Plant-Derived Anticancer Compounds as New Perspectives in Drug Discovery and Alternative Therapy.

Dehelean CA, Marcovici I, Soica C, Mioc M, Coricovac D, Iurciuc S, Cretu OM, Pinzaru I. · 2021

Read Plant-Derived Anticancer Compounds as New Perspectives in Drug Discovery and Alternative Therapy. by Dehelean CA, Marcovici I, Soica C, Mioc M, Coricovac D, Iurciuc S, Cretu OM, Pinzaru I. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7922180.txt.

Introduction

Dehelean and co-authors present a review of plant-derived compounds in cancer drug discovery. Nature remains the main source of active molecules for medicine. Plant compounds hold a large share of current drugs. In cancer care, they offer an answer to the harsh side effects and drug resistance of standard chemotherapy.

The review first revisits classic natural agents such as taxol, vincristine, and doxorubicin. Their ways of killing cancer cells are shown in three-dimensional detail. It then follows newer candidates such as resveratrol, curcumin, and betulinic acid. Each is traced step by step from lab tests toward clinical use. Their action as killers, preventers, and sensitisers of tumours is weighed. Delivery platforms that wrap the compounds and aim them at tumours close the account. The authors argue natural products still have much to give oncology.

Catalog record

CREATORDehelean CA, Marcovici I, Soica C, Mioc M, Coricovac D, Iurciuc S, Cretu OM, Pinzaru I.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE88 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7922180

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Plant-Derived Anticancer Compounds as New Perspectives in Drug Discovery and Alternative Therapy By Cristina Adriana Dehelean, Iasmina Marcovici, Codruta Soica, Marius Mioc, Dorina Coricovac, Stela Iurciuc, Octavian Marius Cretu, Iulia Pinzaru, Gianni Sacchetti Published in: Molecules DOI: 10.3390/molecules26041109 ABSTRACT Abstract Despite the recent advances in the field of chemically synthetized pharmaceutical agents, nature remains the main supplier of bioactive molecules. The research of natural products is a valuable approach for the discovery and development of novel biologically active compounds possessing unique structures and mechanisms of action. Although their use belongs to the traditional treatment regimes, plant-derived compounds still cover a large portion of the current-day pharmaceutical agents. Their medical importance is well recognized in the field of oncology, especially as an alternative to the limitations of conventional chemotherapy (severe side effects and inefficacy due to the occurrence of multi-drug resistance). This review offers a comprehensive perspective of the first blockbuster chemotherapeutic agents of natural origin’s (e.g. taxol, vincristine, doxorubicin) mechanism of action using 3D representation. In addition is portrayed the step-by-step evolution from preclinical to clinical evaluation of the most recently studied natural compounds with potent antitumor activity (e.g. resveratrol, curcumin, betulinic acid, etc.) in terms of anticancer mechanisms of action and the possible indications as chemotherapeutic or chemopreventive agents and sensitizers. Finally, this review describes several efficient platforms for the encapsulation and targeted delivery of natural compounds in cancer treatment Keywords: bioactive compounds; doxorubicin, paclitaxel, vincristine, resveratrol, curcumin, rutin, betulinic acid, antitumoral effect; chemoprevention 1. INTRODUCTION Nature stands as an infinite and inexhaustible resource for the development of novel effective drugs, chemotypes and pharmacophores [1]. Medicinal herbs have a wide outspread globally and, in recent years, have become of essential importance in treating diseases. Their therapeutic role is provided by bioactive molecules, the components of the plant’s chemical core [2]. Since ancient times, natural compounds have played an important role in the treatment and prevention of various pathologies, forming the backbone of the traditional system of healing [3,4]. Furthermore, terrestrial plants (e.g. Artemisia annua L., Camptotheca acuminata Decne., Gingko biloba L., Curcuma longa L., Podophyllum peltatum L., Taxus brevifolia, Taxus baccata, Combretum caffrum, Euphorbia peplus, etc.) still dominate in current-day therapeutic approaches, since the plant-derived compounds comprise a large portion of current pharmaceutical agents, most notably in the areas of antibiotherapy and chemotherapy [4]. The role of natural compounds as drugs or as a basis for the development of new drugs is thoroughly explained in the most recent review published by Newman and Cragg [5]. According to their data, out of a total of 1881 new approved drugs (antibacterial, antifungal, antiviral, antiparasitic, antitumor, etc.) in the last four decades, 929 have natural origin and fall into the class of biological macromolecules, unaltered natural products, botanical drugs, or derivatives of natural products or vaccines, while the other 952 drugs are classified as synthetic drugs, synthetic drugs with natural product pharmacophores or as drugs that mimic a natural product [5]. The use of herbal medicines has been widely embraced as a complementary or alternative option in the oncology field (Catharanthus roseus, Podophyllum peltatum L., Taxus brevifolia Nutt., Taxus baccata, etc.) [3,4]. Therefore, every year, several novel cytotoxic compounds are isolated from plants and constitute new possibilities to fight cancer. Many researchers center their attention on the investigation of naturally occurring molecular entities that might become useful to the pharmaceutical industry [6]. Those who discover compounds exerting antitumor activity during preclinical studies seek out for clinical efficacy confirmation too. Carcinogenesis, the phenomenon of cancer arising and developing, is a step-by-step process [7] characterized by the progression of distinct molecular changes [8], accumulation of mutations and epigenetic alterations that activate oncogenes, inactivation of tumor suppressor genes, hindrance of DNA repair machinery and disruption of apoptosis mechanisms [7], which compels cells to undergo uncontrolled cellular division [8]. A single alteration is not able to promote tumorigenesis, but a collection of multiple modifications that affect cellular homeostasis is necessary to make cells lose control of proliferation [7]. With each disturbance, cells undergo fundamental changes, leading to tumor initiation, promotion and progression [8]. Tumor initiation is a rapid and irreversible process that begins with the exposure to a carcinogenic agent, followed by its transportation to tissues where it causes DNA mutations. During the promotion stage, which is a long and reversible process, the tumor-initiated cells proliferate, allowing the accumulation of additional mutations. The final stage of neoplastic transformation, progression, occurs after these mutations generate an invasive and metastatic cellular phenotype [8]. Regarding cancer therapy, definitive tumor eradication through surgical resection, radiation therapy, immunotherapy and chemotherapy continues to be part of the current mainstay treatment regimens [4,9]. However, the prevention of carcinogenesis is highly preferable to treatment [4], as cancer is largely a preventable disease that can be attributed to lifestyle factors (such as smoking and nutritional status) [10]. The concept of chemoprevention is gaining more public attention especially because it is cost-effective and avoids the toxic side effects following cancer treatment [10]. The benefits of natural compounds as reduced adverse effects and the capacity to impact on multiple signaling pathways involved in the carcinogenesis process could be considered an explanation for the fact that from 240 antitumor drugs approved in the last 40 years, only 29 are strictly synthetic drugs. Moreover, in the past 10 years, synthetic compounds with pharmacophore of natural origin that mimic the natural product effect were approved as antitumor drugs [5]. Phytochemicals have been in the spotlight of cancer research since its early beginnings, as they were among the first antineoplastic drugs discovered (e.g., leucovorin in 1950, carzinophilin in 1954, vincristine in 1963, actinomycin D in 1964, etc.) [5]. Furthermore, their study continued to the present day. It is of great importance to mention that natural compounds not only serve as chemotherapeutic agents, but also as adjuvants in cancer treatment. This review offers a new perspective regarding the role of natural compounds in the oncology field by summarizing the three directions of their anticancer activity: (I) chemotherapeutic agents due to their innate antitumor effect; (II) chemopreventive agents; (III) sensitizers in multi-drug resistance. 2. NATURAL COMPOUNDS RECOGNIZED AS CHEMOTHERAPEUTIC AGENTS 2.1. Natural Compounds Approved as Chemotherapeutic Agents Terrestrial plants, microbes, slime molds and the marine environment represent important sources of novel pharmacologically active molecules, providing a library of promising therapeutic agents [4]. Many blockbuster drugs are directly or indirectly derived from natural products and were or still are in clinical use [1,11,12]. Despite the increased popularity of the synthetic products which led to many drugs existing nowadays [1], the secondary metabolites from plants remain vital for drug design [2], as their core structures serve as templates for the synthesis or semi-synthesis of novel substances for the treatment of diseases affecting humankind [1]. Additionally, while the safety–efficacy report of synthetic drugs remains debatable, the naturally occurring molecules still play a dominant role in the treatment of human ailments [1,4,13] due to their high patient tolerance and acceptance [1]. Conventional chemotherapy drugs (e.g., methotrexate, cisplatin) are associated with severe adverse reactions such as hair loss, gastrointestinal lesion, bone marrow sup-pression, neurologic dysfunction, and drug resistance, while phytocompounds proved to be less toxic and more effective [2,14,15]. Presently, the molecules that occur in nature comprise a

Read the complete text